Aeon Biopharma (AEON) said Monday it is implementing a one-for-72 reverse stock split of its common stock to comply with NYSE American's minimum share value requirement.
The reverse stock split will come into effect starting Wednesday following the board's decision on Feb. 24, Aeon Biopharma said.
No fractional shares will be issued; instead, they will be rounded up to the nearest whole share, the company said.
The company's shares were down nearly 44% in recent trading.
Price: 0.07, Change: -0.05, Percent Change: -43.81
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.